A phase 3, multicenter, prospective, single-blinded, noninferiority, randomized controlled trial on the performance of a novel esophageal stent with an anti-reflux valve (with video)

Self-expanding metal stents (SEMSs) when deployed across the gastroesophageal junction (GEJ) can lead to reflux with risks of aspiration. A SEMS with a tricuspid anti-reflux valve (SEMS-V) was designed to address this issue. The aim of this study was to evaluate the efficacy and safety of this stent.

Source: Gastrointestinal Endoscopy - January 23, 2019 Category: Gastroenterology Authors: Kulwinder S. Dua, John M. DeWitt, William R. Kessler, David L. Diehl, Peter V. Draganov, Mihir S. Wagh, Michel Kahaleh, Louis M. Wong Kee Song, Harshit S. Khara, Abdul H. Khan, Murad M. Aburajab, Darren Ballard, Chris E. Forsmark, Steven A. Edmundowicz, B Source Type: research